Literature DB >> 22284849

Low-titre inhibitors, undetectable by the Nijmegen assay, reduce factor VIII half-life after immune tolerance induction.

M Dardikh, T Albert, R Masereeuw, J Oldenburg, I Novakova, W L van Heerde, B Verbruggen.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22284849     DOI： 10.1111/j.1538-7836.2012.04645.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  5 in total

Review 1.  Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review.

Authors:  C H Miller
Journal:  Haemophilia       Date:  2018-02-15       Impact factor: 4.287

2.  Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors.

Authors:  C H Miller; B Boylan; A D Shapiro; S R Lentz; B M Wicklund
Journal:  J Thromb Haemost       Date:  2017-09-14       Impact factor: 5.824

Review 3.  Progress toward inducing immunologic tolerance to factor VIII.

Authors:  David W Scott; Kathleen P Pratt; Carol H Miao
Journal:  Blood       Date:  2013-03-15       Impact factor: 22.113

4.  Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia A.

Authors:  Laura H Bukkems; Lars L F G Valke; Wideke Barteling; Britta A P Laros-van Gorkom; Nicole M A Blijlevens; Marjon H Cnossen; Waander L van Heerde; Saskia E M Schols; Ron A A Mathôt
Journal:  Br J Clin Pharmacol       Date:  2022-01-15       Impact factor: 3.716

5.  Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation.

Authors:  Lars L F G Valke; Laura H Bukkems; Wideke Barteling; Britta A P Laros-van Gorkom; Nicole M A Blijlevens; Ron A A Mathôt; Waander L van Heerde; Saskia E M Schols
Journal:  J Thromb Haemost       Date:  2020-10-21       Impact factor: 16.036
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.